rxstat › Prices in Nova Scotia › Methylphenidate
Methylphenidate (Concerta) price and coverage in Nova Scotia
Methylphenidate 18 mg tablet (extended-release) lists at $0.52 per tablet in Nova Scotia on Nova Scotia Pharmacare's price list (Nov 1, 2026), before the pharmacy's dispensing fee.
Methylphenidate is covered by Nova Scotia Pharmacare as a regular benefit.
How it compares across Canada
| Alberta | $0.52/tablet |
| Manitoba | $0.52/tablet |
| Ontario | $0.52/tablet |
| New Brunswick | $0.52/tablet |
| Nova Scotia | $0.52/tablet |
| Prince Edward Island | $0.52/tablet |
| British Columbia | $0.57/tablet |
| Newfoundland and Labrador | $0.57/tablet |
| Saskatchewan | $3.30/tablet |
Price by strength in Nova Scotia
| Strength and form | Lowest price | Brand |
|---|---|---|
| 18 mg Tablet (Extended-Release)4 products · covered | $0.52/tablet | – |
| 27 mg Tablet (Extended-Release)4 products · covered | $0.61/tablet | – |
| 36 mg Tablet (Extended-Release)4 products · covered | $0.69/tablet | – |
| 54 mg Tablet (Extended-Release)4 products · covered | $0.85/tablet | – |
| 10 mg Tablet3 products · covered | $0.22/tablet | – |
| 20 mg Tablet3 products · covered | $0.34/tablet | – |
| 20 mg Tablet (Extended-Release)2 products · covered | $0.68/tablet | – |
| 5 mg Tablet2 products · covered | $0.095/tablet | – |
| 10 mg Capsule (Extended-Release)2 products · special approval | $0.51/capsule | – |
| 15 mg Capsule (Extended-Release)2 products · special approval | $0.74/capsule | – |
| 20 mg Capsule (Extended-Release)2 products · special approval | $0.95/capsule | – |
| 30 mg Capsule (Extended-Release)2 products · special approval | $1.30/capsule | – |
| 40 mg Capsule (Extended-Release)2 products · special approval | $1.66/capsule | – |
| 50 mg Capsule (Extended-Release)2 products · special approval | $2.01/capsule | – |
| 60 mg Capsule (Extended-Release)2 products · special approval | $2.34/capsule | – |
| 80 mg Capsule (Extended-Release)2 products · special approval | $3.09/capsule | – |
| 25 mg Capsule (Controlled-Release)1 product · covered | $2.97/capsule | – |
| 35 mg Capsule (Controlled-Release)1 product · covered | $3.26/capsule | – |
| 45 mg Capsule (Controlled-Release)1 product · covered | $3.55/capsule | – |
| 55 mg Capsule (Controlled-Release)1 product · covered | $3.84/capsule | – |
| 70 mg Capsule (Controlled-Release)1 product · covered | $4.28/capsule | – |
| 85 mg Capsule (Controlled-Release)1 product · covered | $4.70/capsule | – |
| 100 mg Capsule (Controlled-Release)1 product · covered | $5.13/capsule | – |
All 49 products listed in Nova Scotia
| Product | Price | Coverage |
|---|---|---|
| 18 mg Tablet (Extended-Release) | ||
| ConcertaJAN · DIN 02247732 | $0.52/tablet | Covered |
| Act Methylphenidate ErTEV · DIN 02441934 | $0.52/tablet | Covered |
| Apo-Methylphenidate ErAPX · DIN 02452731 | $0.52/tablet | Covered |
| Taro-Methylphenidate ErSUN · DIN 02539004 | $0.52/tablet | Covered |
| 27 mg Tablet (Extended-Release) | ||
| ConcertaJAN · DIN 02250241 | $0.61/tablet | Covered |
| Act Methylphenidate ErTEV · DIN 02441942 | $0.61/tablet | Covered |
| Apo-Methylphenidate ErAPX · DIN 02452758 | $0.61/tablet | Covered |
| Taro-Methylphenidate ErSUN · DIN 02539012 | $0.61/tablet | Covered |
| 36 mg Tablet (Extended-Release) | ||
| ConcertaJAN · DIN 02247733 | $0.69/tablet | Covered |
| Act Methylphenidate ErTEV · DIN 02441950 | $0.69/tablet | Covered |
| Apo-Methylphenidate ErAPX · DIN 02452766 | $0.69/tablet | Covered |
| Taro-Methylphenidate ErSUN · DIN 02539020 | $0.69/tablet | Covered |
| 54 mg Tablet (Extended-Release) | ||
| ConcertaJAN · DIN 02247734 | $0.85/tablet | Covered |
| Apo-Methylphenidate ErAPX · DIN 02330377 | $0.85/tablet | Covered |
| Act Methylphenidate ErTEV · DIN 02441969 | $0.85/tablet | Covered |
| Taro-Methylphenidate ErSUN · DIN 02539039 | $0.85/tablet | Covered |
| 10 mg Tablet | ||
| Pms-MethylphenidatePMS · DIN 00584991 | $0.22/tablet | Covered |
| Apo-MethylphenidateAPX · DIN 02249324 | $0.22/tablet | Covered |
| Ritalin 10mgNVR · DIN 00005606 | – | Not covered |
| 20 mg Tablet | ||
| Pms-MethylphenidatePMS · DIN 00585009 | $0.34/tablet | Covered |
| Apo-MethylphenidateAPX · DIN 02249332 | $0.34/tablet | Covered |
| Ritalin 20mgNVR · DIN 00005614 | – | Not covered |
| 20 mg Tablet (Extended-Release) | ||
| Aa-Methylphenidate SrAPX · DIN 02266687 | $0.68/tablet | Covered |
| Ritalin-Sr Tab 20mgNVR · DIN 00632775 | – | Not covered |
| 5 mg Tablet | ||
| Pms-MethylphenidatePMS · DIN 02234749 | $0.095/tablet | Covered |
| Apo-MethylphenidateAPX · DIN 02273950 | $0.095/tablet | Covered |
| 10 mg Capsule (Extended-Release) | ||
| BiphentinELV · DIN 02277166 | $0.51/capsule | Special approval |
| Pms-Methylphenidate CrPMS · DIN 02536943 | $0.51/capsule | Special approval |
| 15 mg Capsule (Extended-Release) | ||
| BiphentinELV · DIN 02277131 | $0.74/capsule | Special approval |
| Pms-Methylphenidate CrPMS · DIN 02536951 | $0.74/capsule | Special approval |
| 20 mg Capsule (Extended-Release) | ||
| BiphentinELV · DIN 02277158 | $0.95/capsule | Special approval |
| Pms-Methylphenidate CrPMS · DIN 02536978 | $0.95/capsule | Special approval |
| 30 mg Capsule (Extended-Release) | ||
| BiphentinELV · DIN 02277174 | $1.30/capsule | Special approval |
| Pms-Methylphenidate CrPMS · DIN 02536986 | $1.30/capsule | Special approval |
| 40 mg Capsule (Extended-Release) | ||
| BiphentinELV · DIN 02277182 | $1.66/capsule | Special approval |
| Pms-Methylphenidate CrPMS · DIN 02536994 | $1.66/capsule | Special approval |
| 50 mg Capsule (Extended-Release) | ||
| BiphentinELV · DIN 02277190 | $2.01/capsule | Special approval |
| Pms-Methylphenidate CrPMS · DIN 02537001 | $2.01/capsule | Special approval |
| 60 mg Capsule (Extended-Release) | ||
| BiphentinELV · DIN 02277204 | $2.34/capsule | Special approval |
| Pms-Methylphenidate CrPMS · DIN 02537028 | $2.34/capsule | Special approval |
| 80 mg Capsule (Extended-Release) | ||
| BiphentinELV · DIN 02277212 | $3.09/capsule | Special approval |
| Pms-Methylphenidate CrPMS · DIN 02537036 | $3.09/capsule | Special approval |
| 25 mg Capsule (Controlled-Release) | ||
| FoquestELV · DIN 02470292 | $2.97/capsule | Covered |
| 35 mg Capsule (Controlled-Release) | ||
| FoquestELV · DIN 02470306 | $3.26/capsule | Covered |
| 45 mg Capsule (Controlled-Release) | ||
| FoquestELV · DIN 02470314 | $3.55/capsule | Covered |
| 55 mg Capsule (Controlled-Release) | ||
| FoquestELV · DIN 02470322 | $3.84/capsule | Covered |
| 70 mg Capsule (Controlled-Release) | ||
| FoquestELV · DIN 02470330 | $4.28/capsule | Covered |
| 85 mg Capsule (Controlled-Release) | ||
| FoquestELV · DIN 02470349 | $4.70/capsule | Covered |
| 100 mg Capsule (Controlled-Release) | ||
| FoquestELV · DIN 02470357 | $5.13/capsule | Covered |
What you'll pay at the pharmacy
These are the prices Nova Scotia Pharmacare lists for the drug itself. The pharmacy adds a dispensing fee and sometimes a markup, so paying cash costs more. If you have coverage, your share depends on your deductible and co-pay.
Shortage status
Partial shortage Supply is affected in Canada: see shortage status.
Methylphenidate price in other provinces
Common questions
How much does Methylphenidate cost in Nova Scotia?
Methylphenidate 18 mg tablet (extended-release) lists at $0.52 per tablet in Nova Scotia on Nova Scotia Pharmacare's price list (Nov 1, 2026), before the pharmacy's dispensing fee.
Is Methylphenidate covered in Nova Scotia?
Methylphenidate is covered by Nova Scotia Pharmacare as a regular benefit.
Is Methylphenidate cheaper in another province?
For 18 mg tablet (extended-release), listed prices run from $0.52 to $3.30 across 9 provinces. Public plans only cover their own residents, though.
Source: Nova Scotia Pharmacare Formulary (Nov 1, 2026). Public plan list prices per unit, before pharmacy fees and markup. This page is not medical advice.